维普期刊资源整合服务平台（V6.5）

199篇 您的检索式：作者名="Gohla"

选中清除导出查看参考文献查看引证文献引用追踪共10页首页上一页第1页下一页末页 /10 跳转

	题名	作者	年代	出处	被引量
1	Solid lipid nanoparticles (SLN)for controlled drug delivery-a review of the state of the art显示文摘	Muller RII Mader K Gohla S	2000	Eur J Pharm Biopham2000，50，1：	2
2	Solid lipid nanoparticles (SLN) for controlled drug delivery – a review of the state of the art显示文摘	Rainer H. Müller Karsten M?der Sven Gohla	2000	European Journal of Pharmaceutics and Biopharmaceutics2000，，1：	2
3	Solid lipid nano- particles (SLN) for controlled drug delivery - a review of the state of the art 显示文摘	MOLLER R H MADER K GOHLA S	2000	Eur J Pharm Biopharm2000，50，：	1
4	Solid lipid nanopartieles ( SLN ) for controlled drug delivery --a review of the state of the art显示文摘	Mailer R H Mader K Gohla S	2000	Eur J Pharm Biopharm2000，50，1：	1
5	Solid lipid nanoparticles(SLN) for controlled drug delivery: a review of the state of the art 显示文摘	MULLER R H MADER K GOHLA S	2000	Eur J Pharm biopharm2000，50，1：	1
6	Solid lipid nanoparticles (SLN) for controlled drug dclivery-a review of the state of art 显示文摘	Mtiller R H Mader K Gohla S	2000	Eur J Pharm Biopharm2000，，50：	1
7	Charaterisation of a novel solid lipid nanoparticle carrier system based on binary mixtures of liquid and solid lipids显示文摘	JENNING V THUNEMANN A F GOHLA S H	2000	Int J Pharm2000，199，2：	1
8	State of nanocrystals-Special features, production, nano toxicology aspects and intracellular de livery显示文摘	Muller RH Sven Gohla Keck CM	2011	European Journal of Pharmaceutics and Biopharmaceu tics2011，78，：	1
9	A prospective study of tumor and technical factors associated with positive margins in breast-conservation therapy for nonpalpable malignancy显示文摘	Reedijk M Hodgson N Gohla G	2012	Am J Surg2012，204，3：	1
10	Solid lipid nanoparticles( SLN ) for controlled drug delivery-a review of the state of the art显示文摘	MULLER RH KARSTEN M GOHLA S	2000	Eur J Pharm Biopharm2000，50，1：	1
11	Solid lipid nanoparticles (SLN) for controlled drug delivery-a review of the state of the art显示文摘	Muller RH Mader K Gohla S	2000	Eur J Pharm Biopharm2000，50，1：	1
12	Solid lipid nanoparticls (SLN)for controlled drug delivery-a review of the state of the art显示文摘	MILLER R H MADER K GOHLA S	2000	Ear J Pharm Biopharm2000，50，1：	1
13	Production of solid lipid nanoparticles (SLN): scaling up feasibilities显示文摘	A Dingier S Gohla	2002	Microencapsulation2002，，19：	1
14	Solid lipid nanoparticles (SLN)for controlled drug delivery- A review of the state of the art显示文摘	Muller R H Mader K Gohla S	2000	Eur J Pharrn Biopharrn2000，50，1：	1
15	Chronophin, a novel HAD- type serine protein phosphatase, regulates cofilin-dependent actin dynamics显示文摘	Gohla A Birkenfeld J Bokoch GM	2005	Nat Cell Biol2005，7，：	1
16	Solid lipid nanoparticles (SLN^TM) based on binary mixtures of liquid and solid lipids: a1H-NMR study显示文摘	JENNING V MADER K GOHLA SH	2000	Int J Pharm2000，205，12：	1
17	Charac-terization of a novel solid lipid nanoparticle carrier system based on binary mixtures of liquid and solid lipids显示文摘	JENNING V THUENEMANN A F GOHLA S H	2000	Int J Pharm2000，199，2：	1
18	Characterisation of a novel solid lipid nanoparticle carrier system based on binary mixtures of liquid and solid lipids 显示文摘	Jenning V Thunemann A F Gohla S H	2000	Int J Pharm2000，199，2：	1
19	State of the art of anocrystals--special features,production,nanotoxicology spects and intracellular delivery 显示文摘	Müller RH Gohla S Keck CM	2011	Eur J Pharm Biopharm2011，78，1：	1
20	Encapsulation of retinoids in solid lipid nan- oparticles(SLN) 显示文摘	Jenning V Gohla S H	2001	J Microencapsul2001，18，2：	1

返回顶部每页显示：

共10页首页上一页第1页下一页末页 /10 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示